{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:34:19Z","timestamp":1791920059880,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"DGAPA-UNAM"},{"name":"Instituto de Qu\u00edmica, UNAM"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.drudis.2015.02.004","type":"journal-article","created":{"date-parts":[[2015,2,16]],"date-time":"2015-02-16T13:01:41Z","timestamp":1424091701000},"page":"890-898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits"],"prefix":"10.1016","volume":"20","author":[{"given":"Karina","family":"Martinez-Mayorga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall G.","family":"Byler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadna I.","family":"Ramirez-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana E.","family":"Terrazas-Alvares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2015.02.004_bib0250","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/nature09221","article-title":"Chagas disease: a new worldwide challenge","volume":"465","author":"Coura","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2015.02.004_bib0255","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1371\/journal.pntd.0000300","article-title":"The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination","volume":"2","author":"Hotez","year":"2008","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.drudis.2015.02.004_bib0260","doi-asserted-by":"crossref","first-page":"b1283","DOI":"10.1136\/bmj.b1283","article-title":"Chagas disease: Challenges and a roadmap","volume":"338","author":"Reithinger","year":"2009","journal-title":"Br. Med. J."},{"key":"10.1016\/j.drudis.2015.02.004_bib0265","doi-asserted-by":"crossref","first-page":"e718","DOI":"10.1371\/journal.pntd.0000718","article-title":"\u201cManifesto\u201d for advancing the control and elimination of negelcted tropical diseases","volume":"4","author":"Hotez","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.drudis.2015.02.004_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399409001252","article-title":"Trypanocidal drugs: mechanisms, resistance and new targets","volume":"11","author":"Wilkinson","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.drudis.2015.02.004_bib0275","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1021\/jm030549j","article-title":"Synthesis and structure\u2013activity relationships of parasiticidal thiosemicarbazone cystein protease inhibitors against Plasmodium falciparum, Trypanosoma brrucei, and Trypanosoma cruzi","volume":"47","author":"Greenbaum","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0280","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2174\/1381612023396159","article-title":"Chemotherapy of human African trypanosomiasis","volume":"8","author":"Burchmore","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drudis.2015.02.004_bib0285","doi-asserted-by":"crossref","first-page":"e701","DOI":"10.1371\/journal.pntd.0000701","article-title":"Crystal structures of TbCatB and rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei","volume":"4","author":"Kerr","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.drudis.2015.02.004_bib0290","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1128\/AAC.00436-07","article-title":"A cystein protease inhibitor cures Chagas\u2019 disease in an immunodeficient-mouse model of infection","volume":"51","author":"Doyle","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2015.02.004_bib0295","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2174\/1381612013397528","article-title":"The major cysteine proteinase of Trypanosoma cruzi: a valid target for chemotherapy of Chagas disease","volume":"12","author":"Cazzulo","year":"2001","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drudis.2015.02.004_bib0300","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1021\/jm901633v","article-title":"Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy","volume":"53","author":"Brak","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0305","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0969-2126(00)00173-8","article-title":"A target within the target: probing cruzain's P1\u00a2 site to define structural determinants for the Chagas\u2019 disease protease","volume":"8","author":"Brinen","year":"2000","journal-title":"Structure"},{"key":"10.1016\/j.drudis.2015.02.004_bib0310","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1371\/journal.pntd.0000825","article-title":"In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi","volume":"4","author":"Chen","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.drudis.2015.02.004_bib0315","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1021\/jm100488w","article-title":"Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors","volume":"53","author":"Ferreira","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0320","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/pro.5560060801","article-title":"Structural determinants of specificity in the cysteine protease cruzain","volume":"6","author":"Gillmor","year":"1997","journal-title":"Protein Sci."},{"key":"10.1016\/j.drudis.2015.02.004_bib0325","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0968-0896(02)00427-3","article-title":"Crystal structures of reversible ketone-based inhibitors of the cysteine protease cruzain","volume":"11","author":"Huang","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0330","doi-asserted-by":"crossref","first-page":"25697","DOI":"10.1074\/jbc.M109.014340","article-title":"Vinyl sulfones as antiparasitic agents and a structural basis for drug design","volume":"284","author":"Kerr","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0335","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1021\/jm901069a","article-title":"Identification and optimization of inhibitors of trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB","volume":"53","author":"Mott","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0340","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1128\/AAC.01855-13","article-title":"Reversible cystein protease inhibitors show promise for chagas disease cure","volume":"58","author":"Ndao","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2015.02.004_bib0345","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.bmc.2004.12.053","article-title":"Development of a-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease","volume":"13","author":"Choe","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0350","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1016\/j.bmcl.2009.08.098","article-title":"Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases","volume":"19","author":"Bryant","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2015.02.004_bib0355","doi-asserted-by":"crossref","first-page":"e2370","DOI":"10.1371\/journal.pntd.0002370","article-title":"Non-peptidic cruzain inhibitors with trypanocidal activity discovered by virtual screening and in vitro assay","volume":"7","author":"Wiggers","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.drudis.2015.02.004_bib0360","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1016\/j.bmcl.2006.05.041","article-title":"Design, synthesis, and biochemical evaluation of novel cruzain inhibitors with potential application in the treatment of Chagas\u2019 disease","volume":"16","author":"Siles","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2015.02.004_bib0365","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1021\/jm701500e","article-title":"Comprehesive mechanistic analysis of hits from high-throughput and docking screens against \u03b2-lactamase","volume":"51","author":"Babaoglu","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0370","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1021\/jm9009229","article-title":"Divergent modes of enzyme inhibition in a homologous structure\u2013activity series","volume":"52","author":"Ferreira","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0375","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/jm901070c","article-title":"Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease","volume":"53","author":"Jadhav","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0380","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1016\/j.bmc.2012.05.029","article-title":"Furin inhibitors: importance of the positive formal charge and beyond","volume":"20","author":"Lopez-Vallejo","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0385","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1016\/j.bmc.2012.05.029","article-title":"Corrigendum to \u201cFurin inhibitors: importance of the positive formal charge and beyond\u201d","volume":"20","author":"Lopez-Vallejo","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0390","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0003-9861(90)90443-3","article-title":"Inhibition of cathepsin B and papain by peptidyl alpha-keto esters, alpha-keto amides, alpha-diketones, and alpha-keto acids","volume":"2","author":"Hu","year":"1990","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.drudis.2015.02.004_bib0395","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/jm010459j","article-title":"Synthesis and structure\u2013activity relationship study of potent trypanocidal thio semicarbazone inhibitors of trypanosomal cystein protease cruzain","volume":"45","author":"Du","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0400","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bmcl.2004.10.023","article-title":"Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain","volume":"15","author":"Fujii","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2015.02.004_bib0405","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1016\/S0960-894X(03)00756-X","article-title":"Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain","volume":"13","author":"Chiyanzu","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2015.02.004_bib0410","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1016\/j.bmcl.2007.10.056","article-title":"Dipeptidyl-alpha,beta-epoxyesters as potent irreversible inhibitors of the cysteine proteases cruzain and rhodesain","volume":"17","author":"Gonzalez","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2015.02.004_bib0415","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1016\/j.bmcl.2008.06.012","article-title":"Synthesis of macrocyclic trypanosomal cystein protease inhibitors","volume":"18","author":"Chen","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2015.02.004_bib0420","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.1016\/j.bmc.2008.05.038","article-title":"New trypanocidal hybrid compounds from the association of hydrazone moieties and benzofuran heterocycle","volume":"16","author":"Porcal","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0425","doi-asserted-by":"crossref","first-page":"10236","DOI":"10.1016\/j.bmc.2008.10.052","article-title":"Convergent synthesis and cruzain inhibitory activity of novel 2-(N\u2032-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines","volume":"16","author":"Zanatta","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0430","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1021\/jm401709b","article-title":"Synthesis, biological evaluation, and structure\u2013activity relationships of potent noncovalent and nonpeptidic cruzain inhibior as anti-Trypanosoma cruzi agents","volume":"57","author":"Ferreira","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0435","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1021\/ci060117s","article-title":"On outliers and activity cliffs \u2013 why QSAR often disappoints","volume":"46","author":"Maggiora","year":"2006","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.drudis.2015.02.004_bib0445","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jinorgbio.2007.12.005","article-title":"Platinum(II) metal complexes as potential anti-Trypanosoma cruzi agents","volume":"102","author":"Vieites","year":"2008","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0450","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1021\/cr980422f","article-title":"Why does cisplatin reach guanine-N7 with competing S-donor ligands available in the cell?","volume":"99","author":"Reedijk","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.drudis.2015.02.004_bib0455","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jinorgbio.2005.03.014","article-title":"Probing the potential of platinum(II) complexes for the inhibition of thiol-dependent enzymatic activity","volume":"99","author":"van Zutphen","year":"2005","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0460","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1389557043487493","article-title":"Metal complexes as chemotherapeutic agents against tropical diseases: trypanosomiasis, malaria and leishmaniasis","volume":"4","author":"Sanchez-Delgado","year":"2004","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0465","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1021\/jm981074c","article-title":"Cytotoxicity of (2,2\u2032:6\u2032,2\u2033-terpyridine)platinum(II) complexes to Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei","volume":"42","author":"Lowe","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0470","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1021\/jf401019b","article-title":"Systematic mining of generally recognized as safe (GRAS) flavor chemicals for bioactive compounds","volume":"61","author":"Martinez-Mayorga","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.drudis.2015.02.004_bib0491","first-page":"298","volume":"16","author":"Ekins","year":"2011","journal-title":"In silico repositioning of approved drugs for rare and neglected diseases"},{"key":"10.1016\/j.drudis.2015.02.004_bib0475","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1021\/ci400284v","article-title":"Application of computer-aided drug repurposing in the search of new cruzipain inhibitors: discovery of amidodrone and bromocriptine inhibitory effects","volume":"53","author":"Bellera","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.drudis.2015.02.004_bib0480","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd2092","article-title":"Targeting proteases: sucesses, failures and future prospects","volume":"5","author":"Turk","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drudis.2015.02.004_bib0485","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/17460441.2012.668520","article-title":"Use of cystein-reactive small molecules in drug discovery for trypanosomal disease","volume":"7","author":"Nicoll-Griffith","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.drudis.2015.02.004_bib0490","series-title":"Introduction to Protein Structure","year":"1999"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644615000732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644615000732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:23:16Z","timestamp":1761222196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644615000732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1359644615000732"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2015.02.004","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2015.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}